Friday, December 02, 2016 9:59:02 PM
It’s just one more thing that goes to prove that OWCP is not your typical OTC share selling operation. I’ll remind you: Low share structure (a fraction of other Marijuana stocks), NO TOXIC DEBT (Convertible Notes), non-interest bearing financing, real pharmaceutical research with clinic trials, real Doctors on-staff, distribution joint ventures, etc.
When products start being sold in early 2017, OWCP should be forever out of Quarter land, let alone Dime land. With only 135.5 million Outstanding Shares, we’re destined for Dollar land, in my opinion. Not necessarily right away. Granted, I’m still dreaming of the $8/share buyout by Big Pharma. (That’s a Market Value of a hair over $1 Billion — which is 1/3rd the current Market Cap of GWPH.)
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM